Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease

<p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-An...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Polilli Ennio [verfasserIn] Ursini Tamara [verfasserIn] Mazzotta Elena [verfasserIn] Sozio Federica [verfasserIn] Savini Vincenzo [verfasserIn] D'Antonio Domenico [verfasserIn] Barbato Michelino [verfasserIn] Consorte Augusta [verfasserIn] Parruti Giustino [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2012

Schlagwörter:	Methicillin-resistant Osteomyelitis Daptomycin Salvage therapy Antibiotic therapy

Übergeordnetes Werk:	In: Annals of Clinical Microbiology and Antimicrobials - BMC, 2003, 11(2012), 1, p 6
Übergeordnetes Werk:	volume:11 ; year:2012 ; number:1, p 6

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc

DOI / URN:	10.1186/1476-0711-11-6

Katalog-ID:	DOAJ025167022

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ025167022
003	DE-627
005	20230502141827.0
007	cr uuu---uuuuu
008	230226s2012 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1186/1476-0711-11-6 \|2 doi
035			\|a (DE-627)DOAJ025167022
035			\|a (DE-599)DOAJ1c39504792544743b3ae27efa8f48086
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
050		0	\|a RM1-950
050		0	\|a RC109-216
050		0	\|a QR1-502
100	0		\|a Polilli Ennio \|e verfasserin \|4 aut
245	1	0	\|a Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease
264		1	\|c 2012
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a <p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.</p<
650		4	\|a Methicillin-resistant <it<Staphylococcus aureus</it<
650		4	\|a Osteomyelitis
650		4	\|a Daptomycin
650		4	\|a Salvage therapy
650		4	\|a Antibiotic therapy
653		0	\|a Therapeutics. Pharmacology
653		0	\|a Infectious and parasitic diseases
653		0	\|a Microbiology
700	0		\|a Ursini Tamara \|e verfasserin \|4 aut
700	0		\|a Mazzotta Elena \|e verfasserin \|4 aut
700	0		\|a Sozio Federica \|e verfasserin \|4 aut
700	0		\|a Savini Vincenzo \|e verfasserin \|4 aut
700	0		\|a D'Antonio Domenico \|e verfasserin \|4 aut
700	0		\|a Barbato Michelino \|e verfasserin \|4 aut
700	0		\|a Consorte Augusta \|e verfasserin \|4 aut
700	0		\|a Parruti Giustino \|e verfasserin \|4 aut
773	0	8	\|i In \|t Annals of Clinical Microbiology and Antimicrobials \|d BMC, 2003 \|g 11(2012), 1, p 6 \|w (DE-627)359783430 \|w (DE-600)2097873-X \|x 14760711 \|7 nnns
773	1	8	\|g volume:11 \|g year:2012 \|g number:1, p 6
856	4	0	\|u https://doi.org/10.1186/1476-0711-11-6 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/1c39504792544743b3ae27efa8f48086 \|z kostenfrei
856	4	0	\|u http://www.ann-clinmicrob.com/content/11/1/6 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1476-0711 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 11 \|j 2012 \|e 1, p 6

Indexfelder

author_variant	p e pe u t ut m e me s f sf s v sv d d dd b m bm c a ca p g pg
matchkey_str	article:14760711:2012----::ucsflavgteayihatmcnootoyltsasdyehclirssatttpyoocsuestnrnlr
hierarchy_sort_str	2012
callnumber-subject-code	RM
publishDate	2012
allfields	10.1186/1476-0711-11-6 doi (DE-627)DOAJ025167022 (DE-599)DOAJ1c39504792544743b3ae27efa8f48086 DE-627 ger DE-627 rakwb eng RM1-950 RC109-216 QR1-502 Polilli Ennio verfasserin aut Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.</p< Methicillin-resistant <it<Staphylococcus aureus</it< Osteomyelitis Daptomycin Salvage therapy Antibiotic therapy Therapeutics. Pharmacology Infectious and parasitic diseases Microbiology Ursini Tamara verfasserin aut Mazzotta Elena verfasserin aut Sozio Federica verfasserin aut Savini Vincenzo verfasserin aut D'Antonio Domenico verfasserin aut Barbato Michelino verfasserin aut Consorte Augusta verfasserin aut Parruti Giustino verfasserin aut In Annals of Clinical Microbiology and Antimicrobials BMC, 2003 11(2012), 1, p 6 (DE-627)359783430 (DE-600)2097873-X 14760711 nnns volume:11 year:2012 number:1, p 6 https://doi.org/10.1186/1476-0711-11-6 kostenfrei https://doaj.org/article/1c39504792544743b3ae27efa8f48086 kostenfrei http://www.ann-clinmicrob.com/content/11/1/6 kostenfrei https://doaj.org/toc/1476-0711 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2012 1, p 6
spelling	10.1186/1476-0711-11-6 doi (DE-627)DOAJ025167022 (DE-599)DOAJ1c39504792544743b3ae27efa8f48086 DE-627 ger DE-627 rakwb eng RM1-950 RC109-216 QR1-502 Polilli Ennio verfasserin aut Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.</p< Methicillin-resistant <it<Staphylococcus aureus</it< Osteomyelitis Daptomycin Salvage therapy Antibiotic therapy Therapeutics. Pharmacology Infectious and parasitic diseases Microbiology Ursini Tamara verfasserin aut Mazzotta Elena verfasserin aut Sozio Federica verfasserin aut Savini Vincenzo verfasserin aut D'Antonio Domenico verfasserin aut Barbato Michelino verfasserin aut Consorte Augusta verfasserin aut Parruti Giustino verfasserin aut In Annals of Clinical Microbiology and Antimicrobials BMC, 2003 11(2012), 1, p 6 (DE-627)359783430 (DE-600)2097873-X 14760711 nnns volume:11 year:2012 number:1, p 6 https://doi.org/10.1186/1476-0711-11-6 kostenfrei https://doaj.org/article/1c39504792544743b3ae27efa8f48086 kostenfrei http://www.ann-clinmicrob.com/content/11/1/6 kostenfrei https://doaj.org/toc/1476-0711 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2012 1, p 6
allfields_unstemmed	10.1186/1476-0711-11-6 doi (DE-627)DOAJ025167022 (DE-599)DOAJ1c39504792544743b3ae27efa8f48086 DE-627 ger DE-627 rakwb eng RM1-950 RC109-216 QR1-502 Polilli Ennio verfasserin aut Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.</p< Methicillin-resistant <it<Staphylococcus aureus</it< Osteomyelitis Daptomycin Salvage therapy Antibiotic therapy Therapeutics. Pharmacology Infectious and parasitic diseases Microbiology Ursini Tamara verfasserin aut Mazzotta Elena verfasserin aut Sozio Federica verfasserin aut Savini Vincenzo verfasserin aut D'Antonio Domenico verfasserin aut Barbato Michelino verfasserin aut Consorte Augusta verfasserin aut Parruti Giustino verfasserin aut In Annals of Clinical Microbiology and Antimicrobials BMC, 2003 11(2012), 1, p 6 (DE-627)359783430 (DE-600)2097873-X 14760711 nnns volume:11 year:2012 number:1, p 6 https://doi.org/10.1186/1476-0711-11-6 kostenfrei https://doaj.org/article/1c39504792544743b3ae27efa8f48086 kostenfrei http://www.ann-clinmicrob.com/content/11/1/6 kostenfrei https://doaj.org/toc/1476-0711 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2012 1, p 6
allfieldsGer	10.1186/1476-0711-11-6 doi (DE-627)DOAJ025167022 (DE-599)DOAJ1c39504792544743b3ae27efa8f48086 DE-627 ger DE-627 rakwb eng RM1-950 RC109-216 QR1-502 Polilli Ennio verfasserin aut Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.</p< Methicillin-resistant <it<Staphylococcus aureus</it< Osteomyelitis Daptomycin Salvage therapy Antibiotic therapy Therapeutics. Pharmacology Infectious and parasitic diseases Microbiology Ursini Tamara verfasserin aut Mazzotta Elena verfasserin aut Sozio Federica verfasserin aut Savini Vincenzo verfasserin aut D'Antonio Domenico verfasserin aut Barbato Michelino verfasserin aut Consorte Augusta verfasserin aut Parruti Giustino verfasserin aut In Annals of Clinical Microbiology and Antimicrobials BMC, 2003 11(2012), 1, p 6 (DE-627)359783430 (DE-600)2097873-X 14760711 nnns volume:11 year:2012 number:1, p 6 https://doi.org/10.1186/1476-0711-11-6 kostenfrei https://doaj.org/article/1c39504792544743b3ae27efa8f48086 kostenfrei http://www.ann-clinmicrob.com/content/11/1/6 kostenfrei https://doaj.org/toc/1476-0711 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2012 1, p 6
allfieldsSound	10.1186/1476-0711-11-6 doi (DE-627)DOAJ025167022 (DE-599)DOAJ1c39504792544743b3ae27efa8f48086 DE-627 ger DE-627 rakwb eng RM1-950 RC109-216 QR1-502 Polilli Ennio verfasserin aut Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease 2012 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier <p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.</p< Methicillin-resistant <it<Staphylococcus aureus</it< Osteomyelitis Daptomycin Salvage therapy Antibiotic therapy Therapeutics. Pharmacology Infectious and parasitic diseases Microbiology Ursini Tamara verfasserin aut Mazzotta Elena verfasserin aut Sozio Federica verfasserin aut Savini Vincenzo verfasserin aut D'Antonio Domenico verfasserin aut Barbato Michelino verfasserin aut Consorte Augusta verfasserin aut Parruti Giustino verfasserin aut In Annals of Clinical Microbiology and Antimicrobials BMC, 2003 11(2012), 1, p 6 (DE-627)359783430 (DE-600)2097873-X 14760711 nnns volume:11 year:2012 number:1, p 6 https://doi.org/10.1186/1476-0711-11-6 kostenfrei https://doaj.org/article/1c39504792544743b3ae27efa8f48086 kostenfrei http://www.ann-clinmicrob.com/content/11/1/6 kostenfrei https://doaj.org/toc/1476-0711 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 11 2012 1, p 6
language	English
source	In Annals of Clinical Microbiology and Antimicrobials 11(2012), 1, p 6 volume:11 year:2012 number:1, p 6
sourceStr	In Annals of Clinical Microbiology and Antimicrobials 11(2012), 1, p 6 volume:11 year:2012 number:1, p 6
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Methicillin-resistant <it<Staphylococcus aureus</it< Osteomyelitis Daptomycin Salvage therapy Antibiotic therapy Therapeutics. Pharmacology Infectious and parasitic diseases Microbiology
isfreeaccess_bool	true
container_title	Annals of Clinical Microbiology and Antimicrobials
authorswithroles_txt_mv	Polilli Ennio @@aut@@ Ursini Tamara @@aut@@ Mazzotta Elena @@aut@@ Sozio Federica @@aut@@ Savini Vincenzo @@aut@@ D'Antonio Domenico @@aut@@ Barbato Michelino @@aut@@ Consorte Augusta @@aut@@ Parruti Giustino @@aut@@
publishDateDaySort_date	2012-01-01T00:00:00Z
hierarchy_top_id	359783430
id	DOAJ025167022
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ025167022</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502141827.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2012 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1476-0711-11-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ025167022</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ1c39504792544743b3ae27efa8f48086</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC109-216</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR1-502</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Polilli Ennio</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2012</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.</p<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Methicillin-resistant <it<Staphylococcus aureus</it<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Osteomyelitis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Daptomycin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Salvage therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibiotic therapy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Infectious and parasitic diseases</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Microbiology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ursini Tamara</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mazzotta Elena</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sozio Federica</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Savini Vincenzo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D'Antonio Domenico</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Barbato Michelino</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Consorte Augusta</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Parruti Giustino</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Annals of Clinical Microbiology and Antimicrobials</subfield><subfield code="d">BMC, 2003</subfield><subfield code="g">11(2012), 1, p 6</subfield><subfield code="w">(DE-627)359783430</subfield><subfield code="w">(DE-600)2097873-X</subfield><subfield code="x">14760711</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2012</subfield><subfield code="g">number:1, p 6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1186/1476-0711-11-6</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/1c39504792544743b3ae27efa8f48086</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.ann-clinmicrob.com/content/11/1/6</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1476-0711</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2012</subfield><subfield code="e">1, p 6</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Polilli Ennio
spellingShingle	Polilli Ennio misc RM1-950 misc RC109-216 misc QR1-502 misc Methicillin-resistant <it<Staphylococcus aureus</it< misc Osteomyelitis misc Daptomycin misc Salvage therapy misc Antibiotic therapy misc Therapeutics. Pharmacology misc Infectious and parasitic diseases misc Microbiology Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease
authorStr	Polilli Ennio
ppnlink_with_tag_str_mv	@@773@@(DE-627)359783430
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RM1-950
illustrated	Not Illustrated
issn	14760711
topic_title	RM1-950 RC109-216 QR1-502 Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease Methicillin-resistant <it<Staphylococcus aureus</it< Osteomyelitis Daptomycin Salvage therapy Antibiotic therapy
topic	misc RM1-950 misc RC109-216 misc QR1-502 misc Methicillin-resistant <it<Staphylococcus aureus</it< misc Osteomyelitis misc Daptomycin misc Salvage therapy misc Antibiotic therapy misc Therapeutics. Pharmacology misc Infectious and parasitic diseases misc Microbiology
topic_unstemmed	misc RM1-950 misc RC109-216 misc QR1-502 misc Methicillin-resistant <it<Staphylococcus aureus</it< misc Osteomyelitis misc Daptomycin misc Salvage therapy misc Antibiotic therapy misc Therapeutics. Pharmacology misc Infectious and parasitic diseases misc Microbiology
topic_browse	misc RM1-950 misc RC109-216 misc QR1-502 misc Methicillin-resistant <it<Staphylococcus aureus</it< misc Osteomyelitis misc Daptomycin misc Salvage therapy misc Antibiotic therapy misc Therapeutics. Pharmacology misc Infectious and parasitic diseases misc Microbiology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Annals of Clinical Microbiology and Antimicrobials
hierarchy_parent_id	359783430
hierarchy_top_title	Annals of Clinical Microbiology and Antimicrobials
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)359783430 (DE-600)2097873-X
title	Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease
ctrlnum	(DE-627)DOAJ025167022 (DE-599)DOAJ1c39504792544743b3ae27efa8f48086
title_full	Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease
author_sort	Polilli Ennio
journal	Annals of Clinical Microbiology and Antimicrobials
journalStr	Annals of Clinical Microbiology and Antimicrobials
callnumber-first-code	R
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2012
contenttype_str_mv	txt
author_browse	Polilli Ennio Ursini Tamara Mazzotta Elena Sozio Federica Savini Vincenzo D'Antonio Domenico Barbato Michelino Consorte Augusta Parruti Giustino
container_volume	11
class	RM1-950 RC109-216 QR1-502
format_se	Elektronische Aufsätze
author-letter	Polilli Ennio
doi_str_mv	10.1186/1476-0711-11-6
author2-role	verfasserin
title_sort	successful salvage therapy with daptomycin for osteomyelitis caused by methicillin-resistant <it<staphylococcus aureus </it<in a renal transplant recipient with fabry-anderson disease
callnumber	RM1-950
title_auth	Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease
abstract	<p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.</p<
abstractGer	<p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.</p<
abstract_unstemmed	<p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.</p<
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	1, p 6
title_short	Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease
url	https://doi.org/10.1186/1476-0711-11-6 https://doaj.org/article/1c39504792544743b3ae27efa8f48086 http://www.ann-clinmicrob.com/content/11/1/6 https://doaj.org/toc/1476-0711
remote_bool	true
author2	Ursini Tamara Mazzotta Elena Sozio Federica Savini Vincenzo D'Antonio Domenico Barbato Michelino Consorte Augusta Parruti Giustino
author2Str	Ursini Tamara Mazzotta Elena Sozio Federica Savini Vincenzo D'Antonio Domenico Barbato Michelino Consorte Augusta Parruti Giustino
ppnlink	359783430
callnumber-subject	RM - Therapeutics and Pharmacology
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.1186/1476-0711-11-6
callnumber-a	RM1-950
up_date	2024-07-03T13:23:25.096Z
_version_	1803564356837834752
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ025167022</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502141827.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2012 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1476-0711-11-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ025167022</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ1c39504792544743b3ae27efa8f48086</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC109-216</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR1-502</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Polilli Ennio</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2012</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a"><p<Abstract</p< <p<Daptomycin is licensed in adults for the management of <it<Staphylococcus aureus </it<methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg/Kg/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.</p<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Methicillin-resistant <it<Staphylococcus aureus</it<</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Osteomyelitis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Daptomycin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Salvage therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibiotic therapy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Infectious and parasitic diseases</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Microbiology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ursini Tamara</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mazzotta Elena</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sozio Federica</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Savini Vincenzo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D'Antonio Domenico</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Barbato Michelino</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Consorte Augusta</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Parruti Giustino</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Annals of Clinical Microbiology and Antimicrobials</subfield><subfield code="d">BMC, 2003</subfield><subfield code="g">11(2012), 1, p 6</subfield><subfield code="w">(DE-627)359783430</subfield><subfield code="w">(DE-600)2097873-X</subfield><subfield code="x">14760711</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2012</subfield><subfield code="g">number:1, p 6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1186/1476-0711-11-6</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/1c39504792544743b3ae27efa8f48086</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.ann-clinmicrob.com/content/11/1/6</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1476-0711</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2012</subfield><subfield code="e">1, p 6</subfield></datafield></record></collection>
score	7.400324

Nicht das Richtige dabei?

Schreiben Sie uns!

Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant <it<Staphylococcus aureus </it<in a renal transplant recipient with Fabry-Anderson disease

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?